Search - tctmd.com

Displaying 121 - 140 of 2115

Sort: Relevancy | Date

News Daily News

Cardiologist Robert Califf Nominated to Head FDA—Again

Shelley Wood

November 12, 2021

News Daily News

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

L.A. McKeown

November 11, 2021

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Caitlin E. Cox

November 11, 2021

Podcast TCTMD Talking Points

The RIVER Trial

November 10, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

News Conference News TCT 2021

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

Caitlin E. Cox

November 09, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 2

Todd Neale

November 08, 2021

Presentation TCT 2021

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

Presenter: Evelio Rodriguez

November 06, 2021

Presentation TCT 2021

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

Presenter: Martin Leon

November 06, 2021

Presentation TCT 2021

AccuCinch: Outcomes of Transcatheter LV Volume Reduction in HFrEF With a Transcatheter Ventricular Restoration System

Presenter: Ulrich Jorde

November 06, 2021

Presentation TCT 2021

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

Presenter: Pasi Karjalainen

November 06, 2021

Presentation TCT 2021

When Bad Things Happen to Good People: Avoiding and Managing PFO Complications

Presenter: Carey Kimmelstiel

November 06, 2021

Presentation TCT 2021

Femoral Venous Pathway Obstruction: Alternate Vascular Approaches

Presenter: John Rhodes

November 06, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

Long, Rigid Tunnels

Presenter: Megan Coylewright

November 06, 2021

Presentation TCT 2021

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Presenter: Alexandra Lansky

November 06, 2021

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

Presentation TCT 2021

Aneurysmal Septum Primum

Presenter: John M. Lasala

November 06, 2021

Advertisement

Cardiologist Robert Califf Nominated to Head FDA—Again

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

The RIVER Trial

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

COVID-19: TCTMD’s Dispatch for November Week 2

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

AccuCinch: Outcomes of Transcatheter LV Volume Reduction in HFrEF With a Transcatheter Ventricular Restoration System

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

When Bad Things Happen to Good People: Avoiding and Managing PFO Complications

Femoral Venous Pathway Obstruction: Alternate Vascular Approaches

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Long, Rigid Tunnels

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Aneurysmal Septum Primum

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content